Categories Earnings, Health Care

Johnson & Johnson Q1 earnings slide on flat revenue growth

Healthcare giant Johnson & Johnson (JNJ) kicked off pharma earnings as it posted its first-quarter 2019 earnings on Tuesday, April 16, before the opening bell.

Reported revenue for the quarter barely changed — inching just 0.1% higher — at $20 billion, while net earnings slipped 14% to $3.7 billion.

On a diluted basis, earnings fell 13% to $1.39 per share.

Johnson and Johnson JNJ Q1 2019 Earnings Infographic

On a non-GAAP basis, operational sales improved 4% year-over-year, while adjusted operational sales grew 5.5%. Adjusted net earnings inched 0.5% higher to $5.7 billion and adjusted EPS rose by 2% to $2.10 per diluted share.

For Johnson & Johnson, US sales inched 2% higher to $10.1 billion. However, international sales slipped about 2% to $9.9 billion.

Consumer sales slowed by 2% to $3.3 billion and Medical Devices sales slumped 5% to $6.5 billion, while Pharmaceuticals top-line improved 4% to $10.2 billion.

Johnson & Johnson said in a statement that “the company is unable to predict with reasonable certainty the ultimate outcome of legal proceedings, unusual gains and losses, acquisition-related expenses and purchase accounting fair value adjustments without unreasonable effort.”

JNJ now expects adjusted FY2019 operational sales to rise 2.5-3.5%. Operational sales is expected to be $82.0-82.8 billion for the year.

“Our strong first-quarter results reflect continued underlying operational sales and adjusted EPS growth,” said CEO Alex Gorsky

“At the same time, we remain focused on investing in innovative technologies and platforms that will make a meaningful difference in the lives of patients around the world. I am proud of our global colleagues’ collective efforts to deliver on our long-term goals and our ability to create value for all of our stakeholders,” the JNJ chief added as Johnson & Johnson posted its first-quarter results.

 

 

Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Infographic: How UnitedHealth Group (UNH) performed in Q2 2024

UnitedHealth Group (NYSE: UNH) reported second quarter 2024 earnings results today. Revenues increased to $98.9 billion from $92.9 billion a year ago. Net earnings attributable to UnitedHealth Group common shareholders

SCHW Earnings: Highlights of Charles Schwab Corporation’s Q2 2024 results

Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Tuesday reported a decrease in adjusted earnings and a modest increase in revenues for the second quarter of 2024. Total

BAC Earnings: Key quarterly highlights from Bank of America’s Q2 2024 financial results

Bank of America (NYSE: BAC) reported its second quarter 2024 earnings results today. Revenue, net of interest expense, of $25.4 billion increased 1% from the prior-year period, reflecting higher asset

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top